Delivery Order SPE2DB20D3103-SPE2DB24FL9S7
Award Date 12/18/23
Potential Completion Date 12/19/23
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,785,987 units of the medication Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $2,998.85 and a completion date of February 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Ondansetron HCL 8 mg tablets. The fixed-price contract has a ceiling value of $1,472.38 and an ultimate completion date of January 8, 2024. This delivery order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for 4,560,886,465 units of Ondansetron HCL 4 mg tablets. The $20,262.06 firm-fixed-price contract has a completion date of May 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $3,271.74 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 500 units of Ondansetron HCL 4 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ondansetron HCL 4 mg tablets. The delivery order, valued at $5,182.86, is issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, with a ceiling value of $999,999,999.00 and a performance period through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,852.21, is for the delivery of Ondansetron ODT 8 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with a potential value of $28,215.71. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 4,563,004,072 units of Ondansetron HCL 4 mg Tablets. This contract is part of a larger IDC held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron HCL 4 mg Tablets. The contract has a ceiling value of $13,034.96 and an ultimate completion date of May 22, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,179.76, is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 8 mg Tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $24,190.99 firm-fixed-price delivery order is for the supply of Ondansetron HCL 8 MG tablets. The contract has an ultimate completion date of January 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL9S7Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $4,476.31 and a completion date of December 19, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 10:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 12/18/23 |